Essex Bio-Technology Limited (1061.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.14B |
| Enterprise Value | 1.7B |
| P/E Ratio | 4.33 |
| PEG Ratio | -0.3 |
| Price/Sales Ratio | 0.67 |
| Price/Book Ratio | 0.45 |
| Enterprise/Revenue | 0.4 |
| Enterprise/EBITDA | 1.7 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 1.81B |
| Revenue/Share | 3.04 |
| Gross Profit | 1.62B |
| EBITDA | 479.37M |
| Net Income | 318.09M |
| Diluted EPS | 0.56 |
Balance Sheet
| Total Cash | 807.73M |
| Total Cash/Share | 1.42 |
| Total Debt | 348.99M |
| Total Debt/Equity | 0.14 |
| Current Ratio | 2.15 |
| Book Value Per Share | 4.5 |
Price History
| 52-Week Change | -55.27 |
| 52-Week High | 4.64 |
| 52-Week Low | 1.98 |
| Moving Average 50 Days | 2.19 |
| Moving Average 200 Days | 3.09 |
Statistics
| Average Volume | 286,695 |
| Shares Outstanding | 566M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.12 |
| Trailing Annual Dividend Yield | 5.9 |
| Payout Ratio | 0.3 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
